Pay in 4 interest-free payments of $5.59 Learn more
Ships within 48 hours · Estimated delivery Aug 24 - Aug 29
New treatment options bring hope to the many people with obesity who struggle with this disease and are seeking better options for weight management. The approval was based on results from the phase III SURMOUNT-1 and SURMOUNT-2 trials
, ,
Its dismal prognosis, with a 5-year survival rate below 10%, is largely attributable to late diagnosis, early metastatic dissemination, and profound resistance to conventional chemotherapy and radiotherapy [1]
Independently lab-verified at 99.76% purity with 5.21mg actual content
US$ 22.64
US$ 28.13
US$ 20.04
